Inovio Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.25
|
|
Average Rating
|
2.83
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.30
|
-0.15
|
0.15
|
50.00%
|
|
2022-06-30
|
-0.31
|
-0.46
|
-0.15
|
-48.39%
|
|
2022-03-31
|
-0.34
|
-0.36
|
-0.02
|
-5.88%
|
|
2021-12-31
|
-0.32
|
-0.50
|
-0.18
|
-56.25%
|
|
2021-09-30
|
-0.33
|
-0.29
|
0.04
|
12.12%
|
|
2021-06-30
|
-0.25
|
-0.39
|
-0.14
|
-56.00%
|
|
2021-03-31
|
-0.18
|
-0.27
|
-0.09
|
-50.00%
|
|
2020-12-31
|
-0.22
|
-0.14
|
0.08
|
36.36%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.97
|
|
2021-12-31
|
-1.45
|
|
2020-12-31
|
-1.12
|
|
2019-12-31
|
-1.23
|
|
2018-12-31
|
-1.05
|
|
2017-12-31
|
-1.06
|
|
2016-12-31
|
-1.00
|
|
2015-12-31
|
-0.45
|
|
2014-12-31
|
-0.62
|
|
2013-12-31
|
-1.40
|
|
2012-12-31
|
-0.58
|
|
2011-12-31
|
-0.48
|
|
2010-12-31
|
-0.68
|
|
2009-12-31
|
-1.47
|
|
2008-12-31
|
-1.16
|
|
2007-12-31
|
-1.40
|
|
2006-12-31
|
-1.76
|
|
2005-12-31
|
-4.36
|
|
2004-12-31
|
-2.17
|
|
2003-12-31
|
-4.61
|